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In Brief
The mitochondrial Ca2+ uniporter (MCU)
is a critical mediator of mitochondrial
Ca2+ import, but its physiologic and
pathologic roles remain unclear. Kwong
et al. report MCU’s essential role in acute
mitochondrial Ca2+ uptake in the heart,
where it augments momentary Ca2+-
dependent mitochondrial metabolic
output in response to elevated contractile
demand.
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In the heart, augmented Ca2+ fluxing drives contrac-
tility and ATP generation through mitochondrial Ca2+
loading. Pathologicmitochondrial Ca2+ overloadwith
ischemic injury triggers mitochondrial permeability
transition pore (MPTP) opening and cardiomyocyte
death. Mitochondrial Ca2+ uptake is primarily medi-
ated by the mitochondrial Ca2+ uniporter (MCU).
Here, we generated mice with adult and cardiomyo-
cyte-specific deletion of Mcu, which produced
mitochondria refractory to acute Ca2+ uptake, with
impaired ATP production, and inhibited MPTP
opening upon acute Ca2+ challenge. Mice lacking
Mcu in the adult heart were also protected from acute
ischemia-reperfusion injury. However, resting/basal
mitochondrial Ca2+ levels were normal in hearts of
Mcu-deleted mice, and mitochondria lacking MCU
eventually loaded with Ca2+ after stress stimulation.
Indeed, Mcu-deleted mice were unable to immedi-
ately sprint on a treadmill unless warmed up for
30 min. Hence, MCU is a dedicated regulator of
short-term mitochondrial Ca2+ loading underlying
a ‘‘fight-or-flight’’ response that acutely matches
cardiac workload with ATP production.
INTRODUCTION
Underphysiological conditions,mitochondrialCa2+ loadingserves
as a signal to enhance mitochondrial energetic output, either by
directly binding and activating key dehydrogenases of the tricar-
boxylic acid cycle or by activation of the ATP synthase, thereby
linkingmomentary cardiac contractile Ca2+ cyclingwithmetabolic
output (Glancy and Balaban, 2012). However, prolonged eleva-
tions of intracellular Ca2+ can trigger mitochondrial permeability
transition pore (MPTP) opening, mitochondrial dysfunction, and
cardiomyocyte death (Kwong and Molkentin, 2015).A major pathway for mitochondrial Ca2+ entry is through the
mitochondrial Ca2+ uniporter (MCU) complex, a selective Ca2+
channel that facilitates the voltage-dependent transport of Ca2+
across the mitochondrial inner membrane (Kamer et al., 2014).
The core complex is comprised of the Mcu gene product itself
that forms the pore and the regulatory subunits MICU1, MICU2,
EMRE, and MCUb (Kamer et al., 2014). Specific inhibition of
MCU with pharmacological agents such as ruthenium red and
Ru360 (Matlib et al., 1998; Zazueta et al., 1999) as well as genetic
ablation of MCU complex components blocks acute mitochon-
drial Ca2+ influx (Baughman et al., 2011; De Stefani et al., 2011;
Pan et al., 2013; Sancak et al., 2013). MCU inhibition via drugs
or RNAi also abrogates cell death in numerous in vitro models,
presumably due to less Ca2+ influx and reduced MPTP opening
(Dessi et al., 1995; Groskreutz et al., 1992; Qiu et al., 2013).
Recently, viable mice were generated with global deletion of
the Mcu gene (Pan et al., 2013). Although mitochondria isolated
from these animals had impaired acute Ca2+ uptake, cardiac
structure and function were unaffected. Moreover, whereas
Ca2+-induced MPTP opening was abrogated in purified mito-
chondria lacking Mcu (Pan et al., 2013), cardiac ischemic injury
was not reduced as would be predicted from past results with
Ru360 or ruthenium red (Garcı´a-Rivas et al., 2006; Zhang
et al., 2006). More recently, Wu and colleagues used a car-
diac-specific transgenic approach to overexpress a dominant-
negative MCU protein in the heart and found that MCU function
was required for cardiac pacemaker cell activity to increase
heart rate following catecholamine stimulation (Wu et al., 2015).
RESULTS
Deletion of MCU in the Heart Blocks Acute
Mitochondrial Ca2+ Uptake
To examine the immediate functional effects of the MCU in the
heart, the Mcu locus was targeted with loxP sites (fl) flanking
exons 5 and 6 to generate a conditional loss-of-function allele
(Mcufl/fl; Figure 1A). Mcufl/fl mice were then crossed with mice
expressing a tamoxifen-inducible Cre recombinase (MerCreMer
[MCM]) driven by the cardiomyocyte-specific a-myosin heavyCell Reports 12, 15–22, July 7, 2015 ª2015 The Authors 15
Figure 1. Cardiomyocyte-Specific Deletion of Mcu Impairs Mitochondrial Ca2+ Uptake
(A) Targeting strategy for theMcu locus to generate theMcufl/fl mice where exons 5 and 6 were flanked with LoxP sites (triangles).Mcufl/fl mice were crossed to
a-MHC MerCreMer (MCM) mice to generate the Mcufl/fl-MCM animals.
(B) Tamoxifen dosing to induce MCM activity was given to 8-week-old animals for 4 weeks, followed by examination at 18 weeks of age.
(C) Western blots of MCU and mNCX expression in cardiac mitochondria. The COXI subunit of mitochondrial complex IV was used as a protein-loading control.
(D) Quantification of Ca2+ content from isolated cardiac mitochondria from the indicated genotypes of mice.
(E) Quantification of free [Ca]m content in permeabilized myocytes from the indicated genotypes of mice.
(F) The effect of Ru360 (1 mM) on mitochondrial Ca2+ uptake as measured by calcium-green 5N fluorescence in the solution. Mitochondria were challenged with
100 mM CaCl2 additions (arrows).
(G) Mitochondrial Ca2+ uptake in mitochondria from hearts of Mcufl/fl versus Mcufll/fl-MCM mice. Mitochondria were challenged with 200 mM CaCl2 additions
(arrows).
(H) Measurement of mitochondrial Ca2+ uptake in permeabilized myocytes as assessed by Rhod-2 fluorescence in the indicated groups of mice, with or without
Ru360.
(I) Quantification of Rhod-2 signal 14 min after Ca2+ addition as shown in (H). *p < 0.05 versus Mcufl/fl. All values reported as mean ± SEM.
(J) Measurement of mitochondrial Ca2+ efflux as mediated by mNCX and leak, assessed by Rhod-2 fluorescence in adult cardiomyocytes.
(K) Quantification of rates of mNCX Ca2+ efflux as shown in (J). All values reported as mean ± SEM. *p < 0.05 versus Mcufl/fl.
See also Figure S1.chain promoter (Figure 1A). Mcu deletion was induced in
8-week-old Mcufl/fl-MCM adult mice by administration of tamox-
ifen food for 4 weeks followed by an additional 6-week period
to allow for MCU protein turnover (Figure 1B). Following this
dosing regimen, western blot analyses showed thatMCUprotein
expression was reduced by >80% in the hearts of 18-week-old
Mcufl/fl-MCM animals when compared with Mcufl/fl and MCM
age-matched controls (Figure 1C).
Direct measurement of mitochondrial Ca2+ levels with two
different assays showed no difference in baseline mitochondrial
Ca2+ from control versusMcufl/fl-MCM hearts (Figures 1D and 1E).
However, acute cardiacmitochondrial Ca2+ uptake, as assessed
with the Ca2+-sensitive dye calcium green-5N, was dramatically16 Cell Reports 12, 15–22, July 7, 2015 ª2015 The Authorsinhibited (Figures 1F and 1G). Mcufl/fl control cardiac mitochon-
dria displayed typical mitochondrial Ca2+ uptake with repeated
Ca2+ additions, reflected as the rapid decrease in fluorescence
signal in the test solution after each Ca2+ pulse, which was in-
hibited with Ru360 (Figure 1F). Similar to the Ru360 treatment,
cardiac mitochondria from Mcufl/f-MCM mice also displayed in-
hibited mitochondrial Ca2+ uptake (Figure 1G).
Mitochondrial Ca2+ handling was also measured in permeabi-
lized adult cardiac myocytes isolated from 18-week-old Mcufl/fl
and Mcufl/fl-MCM mice loaded with Rhod-2, a Ca2+-sensitive
dye that accumulates in mitochondria. In this assay, permeabi-
lized Mcufl/fl control myocytes challenged with 2 mM Ca2+ dis-
played a robust increase in mitochondrial Ca2+ levels that was
Figure 2. Loss of MCU from the Adult Heart Does Not Lead to Pathology at Baseline or with Pathologic Stress Stimulation
(A) Time course for the analyses of cardiac function in response to aging following Mcu deletion.
(B) Transverse H&E heart sections at 2003 magnification.
(C) Representative electron micrographs from heart sections. The scale bar represents 500 nm.
(D) Heart-weight normalized to body-weight ratios (HW/BW) at 18 weeks of age.
(E) Echocardiographic measurement of fractional shortening (FS%) at 18 weeks of age.
(F) Heart-weight normalized to HW/BW at 52 weeks of age.
(G) Echocardiographic measurement of FS% at 52 weeks of age.
(H) Time course for generation of mice and analyses of cardiac function following TAC surgery.
(I) H&E-stained transverse heart sections 8 weeks after TAC surgery at 2003 magnification.
(J–L) HW/BW (J), cardiomyocyte cross-sectional area (K), and FS% (L) in the indicated groups of mice 8 weeks following TAC.
All values reported as mean ± SEM. *p < 0.05 versus Mcufl/fl sham.severely blunted in Mcu-deficient cardiomyocytes (Figures 1H
and 1I). Importantly, Ru360 treatment ofMcufl/fl-MCM cardiomyo-
cytes did not confer additional inhibition of mitochondrial Ca2+
uptake (Figures 1H and 1I).
To understand how basal mitochondrial Ca2+ content can
remain unchanged in the face of impaired MCU activity, we
examined themitochondrial Na+/Ca2+ exchanger (mNCX), which
is the major pathway of mitochondrial Ca2+ efflux. Adult cardiac
myocytes were isolated fromMcufl/fl-MCM andMcufl/fl control an-
imals, and mitochondria were loaded with Rhod2 and Ca2+ by
ionophore permeabilization in conjunction with Ru360 treatment
and exposure to buffer containing 2 mMCa2+. To assess the rate
of basal mitochondrial Ca2+ efflux and leak, myocytes were
exposed to buffer devoid of both Ca2+ and Na+ and then
switched to a buffer containing 10 mM Na+ (Figures 1J and
1K). The data show that, whereas leak rates in solution lackingNa+ and Ca2+ were similar, the Na+-induced Ca2+ efflux rate
(mediated via mNCX) was much lower inMcu-deleted myocytes
(Figures 1J and 1K). Interestingly, deletion of Mcu resulted in
reduced mNCX protein expression, which likely serves as the
basis for the observed compensatory decrease in mNCX activity
in the absence of MCU (Figure 1C).
MCU Does Not Regulate Cardiac Adaptation to
Long-Term Stress
Despite thedefect inacutemitochondrialCa2+uptakeobserved in
the hearts of 18-week-old Mcufl/fl-MCM animals, we observed no
pathologic effects such as changes in cellular morphology,
myofilamentormitochondrial ultrastructure, hypertrophic growth,
or cardiac ventricular performance at 18 or even 52 weeks
of aging (Figures 2A–2G). Furthermore, total cardiomyocyte
Ca2+-transient kinetics and amplitude were unaltered, andCell Reports 12, 15–22, July 7, 2015 ª2015 The Authors 17
Figure 3. MCU Is Required for Acute Mito-
chondrial Ca2+ Stress Signaling
(A) Time course for the cardiac ischemia-re-
perfusion experiment.
(B) Representative images of transverse heart
sections stained with 2,3,5-triphenyltetrazolium
chloride following ischemia-reperfusion injury
from the indicated groups. Ischemic area is out-
lined in yellow.
(C) Quantification of the ischemic area versus area
at risk. *p < 0.05 versus all other groups. All values
presented as mean ± SEM.
(D) Cardiomyocyte viability in response to ion-
omycin treatment (625 nM; 24 hr). *p < 0.05 versus
control. All values presented as mean ± SEM.
(E) Mitochondrial swelling in response to Ca2+
challenge (200 mM CaCl2). Controls were 5 mM
cyclosporine A (CsA) and 2 mM Ru360. The red
arrows show the critical experimental group where
swelling is inhibited with Mcu deletion alone.
(F) Quantification of MPTP opening frequency in
permeabilized cardiomyocytes. MPTP opening is
measured by loss of mitochondrial membrane
potential (TMRM signal; inset). Myocytes were
challenged with 100 nM free Ca2+, and 1 mM CsA was used as a control. *p < 0.005 versus control. All values presented as mean ± SEM.
(G) Western blots of CypD, VDAC, and ANT protein expression in purified cardiac mitochondria from the indicated genotypes of mice.sarcoplasmic reticulum Ca2+ load was unchanged inMcufl/fl-MCM
myocytes as compared to Mcufl/fl controls (Figure S1). Taken
together, these results demonstrate that MCU-mediated mito-
chondrial Ca2+ import neither contributes to overall cardiac Ca2+
cycling in the heart nor is it required to support normal cardiac
function and adaptation with aging.
Mouse models with subtle perturbations in baseline cardiac
metabolic function or metabolic reserve often display increased
pathology under stress stimulation, such as with transverse
aortic constriction (TAC) (Abel and Doenst, 2011; Arany et al.,
2006; Smeets et al., 2008; Wu et al., 2012). Hence, we subjected
Mcufl/fl-MCM, Mcufl/fl, and MCM control mice to 8 weeks of car-
diac pressure overload with TAC surgery (Figure 2H). All three
groups of mice showed identical pathologic profiles in response
to TAC (Figures 2I–2L). These results suggest that cardiac adap-
tation to chronic pressure overload is not dependent on MCU-
mediated mitochondrial Ca2+ import.
MCU Mediates Acute Mitochondrial Ca2+ Overload
In Vivo
We next sought to determine whether MCU played a more-se-
lective role in regulating acute Ca2+ responses in the heart, such
as after immediate ischemia-reperfusion injury. Here, 18-week-
old Mcufl/fl-MCM mice and age-matched Mcufl/fl and MCM con-
trol animals were subjected to 1 hr of cardiac ischemia followed
by 24 hr of reperfusion (Figure 3A). Consistent with past data us-
ing Ru360 or ruthenium red, mice with adult and cardiac-spe-
cific deletion of Mcu displayed an 50% reduction in infarct
size compared to Mcufl/fl and MCM controls (Figures 3B and
3C). Correspondingly, Mcu deletion in cultured adult cardio-
myocytes also conferred protection against acute ionomycin-
induced Ca2+ overload cell death (Figure 3D). Mechanistically,
acute Ca2+-induced MPTP opening, as measured in isolated
cardiac mitochondria, was greatly desensitized in Mcufl/fl-MCM18 Cell Reports 12, 15–22, July 7, 2015 ª2015 The Authorsmitochondria as compared to Mcufl/fl controls (Figure 3E). Ana-
lyses of MPTP opening in permeabilized adult cardiomyocytes,
as reflected by loss of mitochondrial membrane potential,
showed inhibition withMcu deletion, which was similar to cyclo-
sporine A (CsA) treatment of WT control myocytes (Figure 3F).
Importantly, expression of MPTP components such as CypD
(cyclophilin D), VDAC (voltage-dependent anion channel), and
ANT (adenine nucleotide translocator) were unaltered with
Mcu deletion (Figure 3G). These results suggest that loss of
MCU in the heart inhibits acute Ca2+-induced MPTP opening,
resulting in decreased cardiomyocyte damage in response to
ischemia-reperfusion injury.
MCU Is Required for Acute Mitochondrial
Metabolic-Contraction Coupling
Oxygen consumption and ATP generation were examined in iso-
lated mitochondria in response to acute Ca2+ loading. At base-
line, Mcufl/fl-MCM and Mcufl/fl control mitochondria displayed
similar rates of mitochondrial oxygen consumption and ATP
synthesis, consistent with unchanged basal Ca2+ levels in the
absence of MCU protein (Figures 4A and 4B). Furthermore, po-
tential alternative pathways of oxidation such as reactive oxygen
species (ROS) production, NADPH oxidation, superoxide dis-
mutase 2 (SOD2) levels, and catalase activity were also unal-
tered with Mcu deletion (Figure S2). However, whereas addition
of exogenous Ca2+ toMcufl/fl control mitochondria resulted in an
approximate 2-fold increase in respiration and ATP production,
this acute effect was blocked by bothMcu deletion and addition
of Ru360 to WT control mitochondria (Figures 4A and 4B).
To further investigate the hypothesis that MCU is mostly dedi-
cated to short-term mitochondrial Ca2+ regulation, we had to
employ an intact system that could sustain extended measure-
ments, such as isolated adult cardiac myocytes treated with
the b-adrenergic receptor agonist isoproterenol. Similar to the
Figure 4. Acute versus Chronic Regulation
of Mitochondrial Ca2+ and Metabolism due
to MCU Activity
(A) State 3 mitochondrial oxygen consumption in
purified cardiac mitochondria from the indicated
mice stimulated with 100 mM Ca2+ with or without
2 mM Ru360. *p < 0.05 versus ADP baseline; #p <
0.05 versus Mcufl/fl Ca2+. All values presented as
mean ± SEM.
(B) Mitochondrial ATP synthesis in isolated mito-
chondria at baseline and stimulated with 400 mM
CaCl2. Five micromolar Ru360 was used as a
control. *p < 0.05 versus ADP baseline; #p < 0.05
versus Mcufl/fl Ca2+. All values presented as
mean ± SEM.
(C) Relative oxygen consumption rates (OCR) of
Mcufl/fl control adult cardiomyocytes with or
without Ru360 (5 mM) in response to 3.125 nM
isoproterenol (ISO).
(D) OCR in Mcufl/fl-MCM versus Mcufl/fl adult car-
diomyocytes in response to 3.125 nM isoproter-
enol. *p < 0.05 versus control. All values presented
as mean ± SEM.
(E) Maximal rates of cardiac contraction as
measured in a closed-chest mouse in response to
increasing doses of dobutamine. Dobutamine was
increased from 0 to 32 ng/g/min and then main-
tained at 32 ng/g/min for an additional hour.
*p < 0.05 versus control. All values presented as
mean ± SEM.
(F) Total mitochondrial Ca2+ content measured
from hearts taken at the indicated time points from
indicated groups of mice following dobutamine
administration of the experiment shown in (E).
*p < 0.05 versus control. All values presented as
mean ± SEM.
(G) Treadmill performance as quantified by
maximum sprint time in the Mcufl/fl-MCM versus
Mcufl/fl controls. Animals were subjected to two
different protocols, where theywere allowed either
a 2-min warm-up or a 30-min warm-up before
reaching maximum sprint speed. *p < 0.05 versus
control. Number of mice used is shown in the bars.
All values presented as mean ± SEM.
See also Figures S2 and S3.Ca2+-induced increase in mitochondrial respiration observed in
isolated mitochondria (Figure 4A), isoproterenol treatment eli-
cited an immediate increase in oxygen consumption in WT, but
not Mcu-deleted, cardiomyocytes or with Ru360 pretreatment
(Figures 4C and 4D). However, over the course of 80 min, the
isoproterenol-stimulated oxygen consumption of the Ru360-in-
hibited andMcu-deleted myocytes slowly caught up to the rates
observed in control myocytes (Figures 4C and 4D). These results
suggest thatMCU is specialized for acutematching ofmitochon-
drial energy output with cardiac metabolic demands but that
long-term Ca2+ homeostasis can be achieved through other
influx pathways.
We also performed in vivo hemodynamic measurements on
Mcufl/fl-MCM and Mcufl/fl control mice challenged with increasing
concentrations of the b-adrenergic receptor agonist dobut-amine. Mcufl/fl control mice showed a greater short-term in-
crease in the maximal rates of cardiac pressure developed
(+dP/dt) compared toMcufl/fl-MCM animals (Figure 4E). However,
with sustained administration of dobutamine at 32 ng/g/min, the
Mcufl/fl-MCM animals were eventually able to achieve similar
maximal rates of ventricular pressure developed as compared
to Mcufl/fl controls (Figure 4E). Correspondingly, measurement
of total cardiac mitochondrial Ca2+ content in Mcufl/fl-MCM and
Mcufl/fl mice showed that, whereas levels were not different at
baseline, short-term administration of dobutamine resulted in
significantly elevated Ca2+ in only the Mcufl/fl control mitochon-
dria (Figure 4F). However, following 30 min of sustained dobut-
amine, the Ca2+ levels in theMcufl/fl-MCMmitochondria were sub-
stantially higher and had caught up to those observed inMcufl/fl
controls (Figure 4F).Cell Reports 12, 15–22, July 7, 2015 ª2015 The Authors 19
Finally, we challengedMcufl/fl-MCM andMcufl/fl control animals
with two contrasting treadmill-running regimens to probe further
into the acute versus chronic physiologic mechanisms of MCU
function (Figure S3). In the first protocol, animals were subjected
to high-intensity sprinting for 20 min at a speed of 20 m/min
but with only a 2-min warm-up period. In the second protocol,
animals were allowed a 30-min warm-up period prior to the
20-min sprinting phase at 20 m/min (Figure S3). Under the short
warm-up/high-intensity sprinting regimen, Mcufl/fl-MCM animals
displayed significantly reduced running capacity as compared
to Mcufl/fl controls, but this difference was lost if the mice were
allowed a long warm-up period (Figure 4G).
DISCUSSION
In this study, we demonstrate that the role of MCU in the heart is
to acutely match augmented cardiac work with mitochondrial
energy output through mitochondrial Ca2+ loading. Indeed,
loss of MCU from the heart resulted in a selective inability to
acutely respond to b-adrenergic receptor stimulation or maximal
forced exercise by augmenting cardiac metabolic capacity as
cardiomyocyte work is enhanced. However, MCU-deficient car-
diomyocytes or deficient mice eventually catch up to controls in
their contractile or metabolic performance, as does total Ca2+
load in the mitochondria.
The proposed model that MCU controls acute mitochondrial
Ca2+ entry is also supported by results observed under patho-
logic conditions. After cardiac ischemia-reperfusion injury, Mcu
deletion in the adult heart was protective, a finding that re-
capitulates the cardioprotection observed with acute Ru360-
mediated MCU inhibition in adult animals (Garcı´a-Rivas et al.,
2006; Zhang et al., 2006). This result is also consistent with
an acute regulatory role for MCU in loading mitochondria with
excessive Ca2+ leading to catastrophic MPTP opening and my-
ocyte necrosis. Whereas cardioprotection was not observed
with the constitutive Mcu deletion described earlier (Pan
et al., 2013), it should be noted that our targeting approach
allowed us to examine uncompensated effects of MCU dele-
tion in the adult heart, thereby circumventing the potential con-
founding metabolic alterations accompanying long-term and
total body MCU loss. Indeed, total somatic Mcu-deleted mice
displayed growth defects, lactic acidosis, and constitutive
phosphorylation of the E1a subunit of the pyruvate dehydro-
genase complex (Pan et al., 2013). Such effects were not
observed in our adult and cardiac-specific Mcu-deleted mice
(Figure S2).
Our proposedmodel also suggests that baselinemitochondrial
Ca2+ levels could be regulated by one or more additional influx
pathways, either with or independent of MCU. For example, Gra-
ier and colleagues showed that as many as five different Ca2+
influx currents can be identified in mitoplasts (Jean-Quartier
et al., 2012), and a new current was identified in mitoplasts
from cells with knockdown of MCU (Bondarenko et al., 2013).
In addition, Letm1 is an H+/Ca2+ antiporter that can mediate en-
ergy-dependent Ca2+ uptake into mitochondria at low cytosolic
Ca2+ concentration (Jianget al., 2013). Finally, both the ryanodine
receptor 1 (RyR1) and transient receptor potential canonical 3
(TRPC3) have been shown to mediate Ca2+ influx into mitochon-20 Cell Reports 12, 15–22, July 7, 2015 ª2015 The Authorsdria independent of the MCU (Beutner et al., 2001; Feng et al.,
2013). One known compensatory alteration that we did observe
was a significant downregulation in mNCX protein expression
and activity, which should partially offset the reduction in acute
Ca2+ influx, hence better maintaining overall calcium homeosta-
sis. In summary,we conclude thatMCU is the acute fight-or-flight
mediator of Ca2+ influx that facilitates immediate increases in
mitochondrial metabolism and ATP production associated with
augmented cardiac contractile performance.
EXPERIMENTAL PROCEDURES
Animals
TheMcu gene-targeting strategy and generation of theMcu chimericmicewas
through theHowardHughesMedical Institute Gene Targeting Core (Figure S4).
These same mice were also provided to Dr. John Elrod for their use in a co-
submitted manuscript published in this same issue (Luongo et al., 2015).
Homozygous Mcufl/fl mice were bred to transgenic mice expressing the
tamoxifen-inducible Cre recombinase under the control of the a-MHC pro-
moter (Sohal et al., 2001). All animal experiments were approved and per-
formed in accordance by Children’s Hospital Medical Center’s Institutional
Animal Care and Use Committee.
Cardiac Functional Analyses, Surgical Procedures, and Treadmill
Running
Echocardiography was performed using a Hewlett Packard SONOS 5500 im-
aging system as previously described (Nakayama et al., 2009). The TACmodel
of cardiac pressure overload was performed as described previously (Kaiser
et al., 2004). Ischemia-reperfusion injury was performed as previously
described (Wilkins et al., 2004). Adult cardiac myocytes were isolated as pre-
viously described (Goonasekera et al., 2012). The enforced sprinting protocols
were performed using an Omni-Pacer LC4/M treadmill (Columbus Instruments
International) and diagrammed in Figure S3.
Respiration in Adult Cardiomyocytes
Respiration in adult cardiomyocytes was measured using a Seahorse XF24
Flux Analyzer (Seahorse Biosciences) as described in Readnower et al. (2012).
Mitochondrial Isolation and Analyses
Cardiac mitochondria were isolated as previously described (Kwong et al.,
2014). Mitochondrial ATP synthesis rates were measured as described in Vi-
ves-Bauza et al. (2007). Mitochondrial swelling assays were conducted as pre-
viously described (Kwong et al., 2014).
Ca2+ Sparks and Transients Measurements
Intact ventricular myocytes were loaded with Fluo-4 AM dye (5 mM Molecular
Probes), and transients and sparks were recorded as previously described
(Erickson et al., 2013; van Oort et al., 2010).
Statistics
All results are presented as mean ± SEM. Statistical significance was
determined by Student’s t test, and p values < 0.05 were considered
significant.
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